MedPath
HSA Approval

BIBAG POWDER FOR HAEMODIALYSIS

SIN10583P

BIBAG POWDER FOR HAEMODIALYSIS

BIBAG POWDER FOR HAEMODIALYSIS

December 22, 1998

FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.

FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.

Regulatory Information

FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.

FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.

Therapeutic

General Sale List

Formulation Information

POWDER, FOR SOLUTION

HEMODIALYSIS

Medical Information

B05ZA

血液透析

Manufacturer Information

FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.

Fresenius Medical Care - SMAD

Active Ingredients

SODIUM BICARBONATE

100%

Sodium bicarbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BIBAG POWDER FOR HAEMODIALYSIS - HSA Approval | MedPath